NCT07215260View on ClinicalTrials.gov

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 4, 2025

Primary Completion Date

November 28, 2025

Study Completion Date

December 22, 2025

Conditions
Healthy
Interventions
DRUG

BI 3000202

BI 3000202

DRUG

Rosuvastatin

Rosuvastatin

DRUG

Digoxin

Digoxin

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY